How USA TODAY rates Mochi Health USA TODAY evaluated Mochi Health across pricing transparency, clinical oversight, medication safety and customer reviews
By decreasing appetite and cravings, these medications may help some individuals break cycles of emotional or impulsive eating
As with other incretin-based therapies, the most frequently reported side effects of retatrutide during the first month of treatment are gastrointestinal in nature
FDA labeling notes postmarketing reports of acute kidney injury in patients treated with semaglutide, the majority in people who had gastrointestinal reactions leading to dehydration, and it instructs patients to promptly report persistent nausea, vomiting, or diarrhea to their healthcare provider
Retrieved 24 April 2022
Some patients may opt for an additional treatment to achieve even better results or to target specific areas as needed.